Physician profile
Faiz Rahman
NPI 1598737041
$1,905.93
in general payments reported to CMS, 2019-2025
10 companies · $636 in 2025
The $636 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.01 · 2022: $56.95 · 2023: $296 · 2024: $861 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Education: $7.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.62 |
| Education | $7.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $423.27 | 2023-2025 | Purified Cortrophin Gel |
| Astrazeneca Pharmaceuticals Lp | $356.02 | 2023-2025 | Airsupra, Breztri, Seroquel |
| Exact Sciences Corporation | $345.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $314.11 | 2022-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $248.20 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $54.10 | 2023-2025 | Shingrix, Arexvy |
| Pfizer INC. | $51.46 | 2019-2024 | |
| Amgen INC. | $48.99 | 2019-2023 | Repatha |
| Lilly USA, LLC | $48.95 | 2025 | Zepbound, Mounjaro |
| Genentech USA, INC. | $15.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiz Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.